Alexander (Allen) Krantz, Chief Operating Officer & Company Secretary at Advanced Proteome Therapeutics, holds 1.75M shares in Advanced Proteome Therapeutics (Ticker: TSE:APC.H). Most recently, Alexander (Allen) Krantz Bought C$400,000 shares of Advanced Proteome Therapeutics on Aug 24, 2018 for an estimated value of 20.00K.
What is the percentage of profitable transactions made by Alexander (Allen) Krantz?
The percentage of profitable transactions made by Alexander (Allen) Krantz is 33%.
What is the average return per transaction made by Alexander (Allen) Krantz?
The average return per transaction made by Alexander (Allen) Krantz is -27.30%.
What stocks does Alexander (Allen) Krantz hold?
Alexander (Allen) Krantz holds: TSE:APC.H stocks.
What was Alexander (Allen) Krantz’s latest transaction?
Alexander (Allen) Krantz latest transaction was an Informative Buy of C$20.00K.
What was Alexander (Allen) Krantz's most profitable transaction?
Alexander (Allen) Krantz’s most profitable transaction was an Informative Buy of TSE:APC.H stock on May 20, 2016. The return on the trade was 24.90%.
What is Alexander (Allen) Krantz's role in Advanced Proteome Therapeutics?
Alexander (Allen) Krantz's role in Advanced Proteome Therapeutics is Chief Operating Officer & Company Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.